Michael Benkowitz

United Therapeutics

President and Chief Operating Officer

Overview

Michael Benkowitz received an average compensation of $8,454,316 at United Therapeutics between 2016 and 2017.

Annual data

2017

Change in Pension Value and Nonqualified Deferred Compensation Earnings$1,043,171
Non-Equity Incentive Plan$738,750
Option Awards$9,017,790
Salary$733,333
Other$24,433
Total$11,557,477

In 2017, Michael Benkowitz earned a total compensation of $11,557,477 as President and Chief Operating Officer at United Therapeutics.

Benkowitz received $9,017,790 in option awards, which accounts for 78.03% of total compensation.

Benkowitz also received $1,043,171 of change in pension value and nonqualified deferred compensation earnings, $738,750 in non-equity incentive plan, $733,333 in salary and $24,433 in other compensation.

2016

Change in Pension Value and Nonqualified Deferred Compensation Earnings$508,653
Non-Equity Incentive Plan$416,000
Option Awards$3,570,563
Salary$568,417
Other$287,522
Total$5,351,155

In 2016, Michael Benkowitz earned a total compensation of $5,351,155 as President and Chief Operating Officer at United Therapeutics.

Benkowitz received $3,570,563 in option awards, which accounts for 66.73% of total compensation.

Benkowitz also received $508,653 of change in pension value and nonqualified deferred compensation earnings, $416,000 in non-equity incentive plan, $568,417 in salary and $287,522 in other compensation.